EU State Actions On BSE Must Be Unified Through CEC Decision - EUCOMED
This article was originally published in The Gray Sheet
Executive Summary
EUCOMED is urging the Commission of European Communities to finalize its draft decision on medical devices incorporating materials of animal origin in order to head off further individual actions by member states.
You may also be interested in...
EC TSE Standards Adoption Vital For Policy Harmonization - MDMA
The European Commission and EU member state experts should rapidly adopt the EC's draft decision on transmissible spongiform encephalopathies (TSEs) and medical devices that incorporate animal materials, the Medical Device Manufacturers Association says in a March 14 letter to EC Commissioner Erkki Liikanen.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.